Nicotinamide Mononucleotide Attenuates LPS-Induced Acute Lung Injury With Anti-Inflammatory, Anti-Oxidative and Anti-Apoptotic Effects

Nov 8, 2022The Journal of surgical research

Nicotinamide Mononucleotide Reduces Lung Injury Caused by LPS Through Anti-Inflammatory, Antioxidant, and Cell-Protection Effects

AI simplified

Abstract

Nicotinamide mononucleotide (NMN) significantly improved lung health in a mouse model of acute lung injury induced by lipopolysaccharide.

  • NMN treatment reduced pathological damage and cell death in lung tissue compared to the LPS group.
  • Levels of inflammatory cytokines TNF-α, IL-1β, and IL-6 in bronchoalveolar lavage fluid were decreased with NMN administration.
  • The total cell count and neutrophil count in bronchoalveolar lavage fluid were lower in the NMN-treated group.
  • NMN lowered the dry-to-wet ratio and malondialdehyde (MDA) content, indicators of lung injury.
  • Phosphorylation levels of p38 MAPK and p65 NF-κB were reduced with NMN treatment, suggesting decreased inflammation.
  • Superoxide dismutase (SOD) activity was increased following NMN treatment, indicating enhanced antioxidative response.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free